Clinical Trial

Do We Really Bleed in Percutaneous Nephrolithotomy? A Single-Surgeon, Single-Center Experience

Completed
View on ClinicalTrials.gov →
Summary
Percutaneous nephrolithotomy (PCNL) is an effective and guideline-recommended surgical technique for the treatment of large and complex renal stones; however, perioperative bleeding remains one of its most significant complications. Reported bleeding and transfusion rates vary widely in the literature, potentially due to differences in surgical technique, surgeon experience, and institutional practices. This retrospective, single-center study aims to evaluate perioperative and postoperative bleeding outcomes, transfusion requirements, and bleeding-related complications in patients who underwent PCNL performed by a single surgeon. The findings are intended to clarify whether the real-world bleeding risk associated with PCNL is lower than commonly reported.
Trial Details
NCT Number NCT07360795
Lead Sponsor Elazıg Fethi Sekin Sehir Hastanesi
Conditions Urolithiasis
Enrollment 500 participants
Start Date 2022-08-01
Primary Completion 2025-12-20 (estimated)
Study Completion 2025-12-20 (estimated)
Updated on ClinicalTrials.gov 2026-01-22